Raya Therapeutic
QC - MontrealBiotechnology
Focus: Raya Therapeutic is a Montreal-based biotechnology company focused on developing compounds for amyotrophic lateral sclerosis (ALS), a severe neurodegenerative disease with high unmet medical need.
Profile data last refreshed 1h ago · AI intelligence enriched 1w ago
Open Jobs
5+1 this month
Stable — net +1 jobs in 30d
3 added, 2 removed. Backfill posture.
Should You Work at Raya Therapeutic?
AI assessmentRaya Therapeutic is a speculative early-stage opportunity best suited for researchers willing to accept pre-clinical risk in exchange for potential equity upside and deep involvement in ALS drug discovery.
Why Work Here
- Opportunity to contribute to a focused neurology program addressing ALS, a disease with significant patient impact and limited treatment options
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Slowing
Jobs decreasing
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Raya Therapeutic
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.